Zada Gabriel, Krieger Mark D, McNatt Sean A, Bowen Ira, McComb J Gordon
Department of Neurosurgery, Childrens Hospital Los Angeles, Keck School of Medicine of University of Southern California, Los Angeles, California 90089, USA.
Neurosurg Focus. 2007;22(2):E1. doi: 10.3171/foc.2007.22.2.1.
Arachnoid cysts can cause a variety of clinical signs and symptoms in infants. The authors sought to determine whether the clinical presentation of pediatric patients younger than 2 years old and harboring arachnoid cysts influenced the type of intervention that would be required.
A retrospective chart review was conducted for all patients younger than 2 years of age who had undergone craniotomy for fenestration of an arachnoid cyst at the Children's Hospital Los Angeles between 1995 and 2006. Forty-two patients were included in the study. The mean age was 10.4 months. The median follow-up time was 33 months. Clinical presentations were as follows: macrocephaly without ventriculomegaly (21 patients, 50%), hydrocephalus (six patients, 14%), and other symptoms (15 patients, 36%). After fenestration of the arachnoid cyst, 12 of 21 patients (57%) presenting with nonspecific macrocephaly required placement of a cystoperitoneal or ventriculoperitoneal shunt, compared with 1 of 15 patients (7%) presenting with other symptoms (p value = 0.0039). Five of six patients with hydrocephalus (83%) were shunt dependent following fenestration. Overall, 18 of 42 patients (43%) were shunt dependent after fenestration. Ten of these patients (55%) required revisions during the follow-up period.
Patients younger than 2 years of age and harboring an arachnoid cyst commonly present with macrocephaly. These patients are more likely to require shunts than are those presenting with other findings, such as seizures or incidental lesions. The development and expansion of arachnoid cysts may be related to aberrant cerebrospinalfluid dynamics, and these lesions may be a form fruste of hydrocephalus. Arachnoid cysts should be treatedwith craniotomy and cyst fenestration, taking into account the likelihood of perioperative shunt dependency.
蛛网膜囊肿可在婴儿中引起多种临床体征和症状。作者试图确定2岁以下患有蛛网膜囊肿的儿科患者的临床表现是否会影响所需的干预类型。
对1995年至2006年期间在洛杉矶儿童医院因蛛网膜囊肿开窗而接受开颅手术的所有2岁以下患者进行回顾性病历审查。42名患者纳入研究。平均年龄为10.4个月。中位随访时间为33个月。临床表现如下:无脑室扩大的巨头畸形(21例患者,50%)、脑积水(6例患者,14%)和其他症状(15例患者,36%)。蛛网膜囊肿开窗后,21例表现为非特异性巨头畸形的患者中有12例(57%)需要放置囊肿-腹腔或脑室-腹腔分流管,而15例表现为其他症状的患者中有1例(7%)需要放置分流管(p值=0.0039)。6例脑积水患者中有5例(83%)在开窗后依赖分流管。总体而言,42例患者中有18例(43%)在开窗后依赖分流管。其中10例患者(55%)在随访期间需要进行分流管修订。
2岁以下患有蛛网膜囊肿的患者通常表现为巨头畸形。与表现为其他症状(如癫痫或偶然发现的病变)的患者相比,这些患者更有可能需要分流管。蛛网膜囊肿的发生和扩大可能与异常的脑脊液动力学有关,这些病变可能是脑积水的一种不完全形式。应考虑围手术期依赖分流管的可能性,采用开颅手术和囊肿开窗术治疗蛛网膜囊肿。